<?xml version="1.0" encoding="UTF-8"?>
<p>This is a randomized, single-blinded, placebo controlled clinical trial. Patients were initially submitted to 24-hour ambulatory blood pressure monitoring according to VI Brazilian guidelines for hypertension [
 <xref rid="B15-nutrients-13-00798" ref-type="bibr">15</xref>]. Blood collection was performed to biochemical analysis. After the initial evaluation, the patients in each group were submitted to food supplementation with EVCO capsules or placebo for a period of 30 days. Twenty-four hours after the last day of this intervention period, patients were again evaluated for initial variable.
</p>
